Sabra Healthcare REIT (NASDAQ:SBRA) Reaches New 1-Year High – Still a Buy?

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $21.28 and last traded at $21.1120, with a volume of 223916 shares trading hands. The stock had previously closed at $21.01.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on SBRA shares. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Monday. Citigroup lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Cantor Fitzgerald lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Truist Financial raised their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, March 13th. Finally, Citizens Jmp raised their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 18th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $22.20.

Sabra Healthcare REIT Trading Up 0.1%

The company has a market capitalization of $5.30 billion, a price-to-earnings ratio of 33.44, a P/E/G ratio of 1.67 and a beta of 0.67. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The company’s 50 day simple moving average is $20.31 and its two-hundred day simple moving average is $19.58.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. The company had revenue of $221.75 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. Sabra Healthcare REIT’s revenue was up 20.9% compared to the same quarter last year. During the same period last year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.7%. The ex-dividend date is Friday, May 15th. Sabra Healthcare REIT’s payout ratio is presently 190.48%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several institutional investors and hedge funds have recently made changes to their positions in SBRA. Principal Financial Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after buying an additional 4,431,897 shares during the period. Lasalle Investment Management Securities LLC acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth $66,938,000. Norges Bank acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth $57,945,000. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 1,019.8% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock worth $56,922,000 after buying an additional 2,736,993 shares during the period. Finally, Balyasny Asset Management L.P. acquired a new stake in shares of Sabra Healthcare REIT during the second quarter worth $49,955,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.